Hodgkin Disease: all 914 studies
Page 7 of 10. Open to participants first (136), then studies with results posted, then the rest; newest registration first within each.
- Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell TransplantCompletedNCT01959477Early Phase 1
- Cytotoxic T Cells to Treat Relapsed EBV-positive LymphomaCompletedNCT01956084Phase 1
- Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell TransplantCompletedNCT01904175
- Temsirolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin LymphomaCompletedNCT01902160Phase 1
- Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin LymphomaTerminatedNCT01900496Phase 1
- Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell LymphomasCompletedNCT01897012Phase 1
- Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma PatientsStatus unknownNCT01884441Phase 2
- Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's LymphomaStatus unknownNCT01884428Phase 1
- A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's LymphomaCompletedNCT01877005Phase 2
- Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin LymphomaCompletedNCT01868451Not applicable
- Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12ACompletedNCT01858922Phase 2
- P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic MalignanciesCompletedNCT01854567Phase 3
- Kinetic of Cytokines Decrease and Hodgkin Lymphoma PrognosticCompletedNCT01833884Not applicable
- Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic RadiationCompletedNCT01820117
- Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed LymphomasCompletedNCT01793233
- Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaWithdrawnNCT01769911Not applicable
- Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma PatientsCompletedNCT01764230Not applicable
- Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood DisordersCompletedNCT01758042Not applicable
- MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaCompletedNCT01748721Phase 1
- Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)TerminatedNCT01745354Phase 1
- An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)TerminatedNCT01742793Phase 1
- Prospective Study of Lymphoproliferative DiseasesWithdrawnNCT01704742
- Assessment of Impact Nutritional Program During Autologous Stem Cell TransplantTerminatedNCT01699581Phase 2
- BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and HematologyCompletedNCT01660776
- Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic MalignanciesCompletedNCT01658319Phase 1
- Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)WithdrawnNCT01652261Phase 3
- Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWithdrawnNCT01652014Phase 2
- Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic MalignanciesTerminatedNCT01643603Phase 1
- Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins LymphomaTerminatedNCT01636388Phase 2
- NK Cells in Cord Blood TransplantationStatus unknownNCT01619761Phase 1
- Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin LymphomaTerminatedNCT01609816Phase 1
- Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell TransplantCompletedNCT01588015Phase 1
- A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin LymphomaCompletedNCT01572519Phase 1
- Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin LymphomaCompletedNCT01569204Phase 2
- Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaCompletedNCT01567709Phase 1
- Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWithdrawnNCT01558778Not applicable
- Phase I/II Study of Abraxane in Recurrent and Refractory LymphomaTerminatedNCT01555853Phase 1
- Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood UnitCompletedNCT01527838Phase 1
- A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL)CompletedNCT01523847Phase 2
- Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid MalignanciesCompletedNCT01523223Phase 1
- Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical TrialCompletedNCT01505712
- Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchTerminatedNCT01500161Phase 2
- Functional Assessment of Cancer Therapy - Bone Marrow TransplantStatus unknownNCT01490957
- Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin LymphomaCompletedNCT01490801
- Music Therapy on Nausea and Pain for Autologous Stem CellCompletedNCT01487031Not applicable
- Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile NeutropeniaCompletedNCT01484015Phase 1
- Communication Skills Intervention to Promote Transition Into SurvivorshipActive, not recruitingNCT01483664
- Prognosis of Patients With Relapsed/Refractory Hodgkin Lymphoma Treated With IGEV Induction Therapy Before HDCT With AHSCTCompletedNCT01478191
- Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin LymphomaCompletedNCT01476839Phase 1
- Prospective Study on HIV-related Hodgkin LymphomaStatus unknownNCT01468740Phase 2
- MELT - MRI Evaluation of Lymphoma TreatmentCompletedNCT01459224
- Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin LymphomaCompletedNCT01453504Phase 1/2
- Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated DiseasesCompletedNCT01447056Phase 1
- Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic MalignanciesCompletedNCT01413568Phase 1/2
- A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin LymphomaStatus unknownNCT01412307Phase 1/2
- Dual Point PET Scan in Early Stage Hodgkin Lymphoma Patients With Bulky LesionsStatus unknownNCT01399931
- Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin LymphomaCompletedNCT01366157
- Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HLCompletedNCT01358747Phase 3
- HD17 for Intermediate Stage Hodgkin LymphomaCompletedNCT01356680Phase 3
- IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin LymphomaStatus unknownNCT01333605Phase 2
- Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTALCompletedNCT01333046Phase 1
- A Study Of Panobinostat In Children With Refractory Hematologic MalignanciesCompletedNCT01321346Phase 1
- Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing ChemotherapyTerminatedNCT01319526
- Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)WithdrawnNCT01316146Phase 1
- Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve OutcomesCompletedNCT01304849Not applicable
- Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)Status unknownNCT01300156Phase 2
- Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell TransplantationCompletedNCT01283776Phase 2
- Screening for Coronary Artery Disease After Mediastinal IrradiationCompletedNCT01271127Not applicable
- A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid MalignanciesCompletedNCT01263899Phase 2
- Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's LymphomaCompletedNCT01251107Phase 3
- The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern ItalyCompletedNCT01248000
- Hybrid SPECT/CTCA for the Assessment of the Presence and Hemodynamic Significance of CAD in Asymptomatic Patients.Status unknownNCT01239446Not applicable
- MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaCompletedNCT01231919Phase 1
- Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma PatientsCompletedNCT01228461
- A Study to Assess AFM13 in Patients With Hodgkin LymphomaCompletedNCT01221571Phase 1
- Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins LymphomaCompletedNCT01207921Phase 1
- Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantActive, not recruitingNCT01199562
- A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001No longer availableNCT01196208
- Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's LymphomaCompletedNCT01195766Phase 2
- EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ LymphomaActive, not recruitingNCT01192464Phase 1
- Personalised Program for Women Treated for Hodgkin DiseaseTerminatedNCT01188915Not applicable
- Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)CompletedNCT01187303Phase 2
- Low Dose Chest Computed Tomography (CT) ScreeningCompletedNCT01180010
- High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaCompletedNCT01177371Phase 2
- Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin LymphomaWithdrawnNCT01165645Not applicable
- Mozobil for Autologous Stem Cell MobilizationCompletedNCT01164345Phase 2
- RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsCompletedNCT01158274Phase 1
- A Safety and Tolerability Study of PCI-24781 in Subjects With CancerCompletedNCT01149668Phase 1
- Blood Samples to Identify Biomarkers in Haploidentical Graft RecipientsCompletedNCT01141959
- B-Receptor Signaling in CardiomyopathyCompletedNCT01135849
- AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaCompletedNCT01129193Phase 1
- Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma PatientsTerminatedNCT01121120Phase 2
- Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaTerminatedNCT01116154Phase 1
- Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin LymphomaCompletedNCT01088750Phase 4
- Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell TransplantationCompletedNCT01087294Phase 1
- Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose TherapyCompletedNCT01085058Phase 2/3
- Consent for Obtaining Additional Tissue at the Time of a Diagnostic BiopsyCompletedNCT01078350
- A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin LymphomaCompletedNCT01060904Phase 1
- Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma PatientsCompletedNCT01056679Phase 1
- Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for CancerCompletedNCT01053494Not applicable